Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
J Oral Maxillofac Pathol ; 27(3): 599, 2023.
Article in English | MEDLINE | ID: mdl-38033965

ABSTRACT

Introduction: Tobacco and areca nuts release carcinogens, which cause alterations in saliva. Evaluation of these changes through estimation of salivary flow rate and pH was performed in tobacco and areca nut chewers and apparently healthy subjects. Material and Methods: The study group for this comparative study comprised 60 subjects with 20 areca nut chewers (group 1), 20 tobacco chewers (group 2), and 20 non-tobacco and areca nut chewers (group 3) in the ages between 18 and 75 years. After collection of saliva from each subject, the salivary flow rate (SFR) was measured by using graduated tubes, whereas salivary pH was measured using a digital salivary pH meter. Tukey HSD post hoc test was performed for comparison of mean SFR and mean pH between study group subjects. Analysis of variance (ANOVA) test was used to find the mean difference in SFR and pH in duration, intensity, and frequency among various types of areca nut and tobacco users. A "P" value of less than 0.05 was considered as statistically significant. Results: The mean age among groups 1, 2, and 3 was 37.70 ± 10.44, 39.75 ± 10.16, and 37.90 ± 10.52 years, respectively, with a statistically insignificant difference. The mean salivary flow rate (ml/20 min) was maximum in group 3 (13.23), followed by group 2 (11.75) and group 1 (10.48), with the statistically significant difference as P < 0.05. The mean salivary pH was maximum in group 3 (7.07), followed by group 2 (6.86) and group 1 (6.49), with the statistically significant difference as P < 0.05. Conclusion: Long-term use of tobacco and areca nuts in a chewable form can significantly reduce the salivary flow rate and salivary pH. Hence, these measurements can be used as chair side, non-invasive measures for assessing pathological changes in oral mucosa linked to vulnerable effects among people addicted to these adverse habits; thereby, early re-organization can prevent mobility and mortality.

2.
Asian Pac J Cancer Prev ; 22(1): 125-129, 2021 Jan 01.
Article in English | MEDLINE | ID: mdl-33507689

ABSTRACT

OBJECTIVE: The current research was conducted with an aim to assess the association of oral microbiome with Potentially malignant disorders (PMDs) because usage of tobacco in any form alters the normal microbiome and shifts it towards dysbiosis. Thus, our definitive knowledge of the oral commensal bacteria and oral cancer link can definitely be used as a potential adjunct to early diagnosis and management of PMDs and prevent it's malignant transformation. STUDY DESIGN: A total of 100 individuals of minimum 18 years of age were included in the study which, were classified into 2 groups of tobacco users (50) and non-tobacco users (50). The tobacco users had a history of tobacco consumption for at least 5 years. RESULTS: The present study, showed highest percentage (72%) of anaerobic bacteria, followed by aerobic (22%) and lowest count of yeast (4%). CONCLUSION: The ecological shift to dysbiosis is a significant finding in oral carcinogenesis. Further investigation on a larger group of altered microbiomes will definitely help in establishing relationship of altered microbiome and PMDs, which can help in appropriate treatment and better prognosis.


Subject(s)
Cell Transformation, Neoplastic/pathology , Dysbiosis/complications , Microbiota , Mouth Neoplasms/diagnosis , Mouth/microbiology , Saliva/microbiology , Adolescent , Adult , Aged , Aged, 80 and over , Case-Control Studies , Dysbiosis/microbiology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Mouth Neoplasms/epidemiology , Mouth Neoplasms/microbiology , Mouth Neoplasms/prevention & control , Prognosis , Young Adult
3.
Indian J Gastroenterol ; 33(1): 23-30, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24006122

ABSTRACT

PURPOSE: Variations in biliary anatomy are common, and different classifications have been described. These classification systems have not been compared to each other in a single cohort. We report such variations in biliary anatomy on magnetic resonance cholangiopancreatography (MRCP) using six different classification systems. METHODS: In 299 patients undergoing MRCP for various indications, biliary anatomy was classified as described by Couinaud (1957), Huang (1996), Karakas (2008), Choi (2003), Champetier (1994), and Ohkubo (2004). Correlation with direct cholangiography and vascular anatomy was done. Bile duct dimensions were measured. Cystic duct junction and pancreaticobiliary ductal junction (PBDJ) were classified. RESULTS: Normal biliary anatomy was noted in 57.8 %. The most common variants were Couinaud type D2, Choi type 3A, Huang type A1, Champetier type a, Ohkubo types D and J, and Karakas type 2a. The Ohkubo classification was the most appropriate; 3.1 % of right ducts and 6.3 % of left ducts with variant anatomy could not be classified using the Ohkubo classification. There was a good agreement between MRCP and direct cholangiography (ĸ = 0.9). Anomalous PBDJ was noted in 8.7 %. Variant biliary anatomy was not associated with gender (p = 0.194) or variant vascular anatomy (p = 0.24). CONCLUSION: Although each classification system has its merits and demerits, some anatomical variations cannot be classified using any of the previously described classifications. The Ohkubo classification system is the most applicable as it considers most clinically relevant variations pertinent to hepatobiliary surgery.


Subject(s)
Anatomy/classification , Bile Ducts/anatomy & histology , Bile Ducts/abnormalities , Cholangiopancreatography, Magnetic Resonance , Cohort Studies , Female , Humans , Male
4.
Cardiovasc Intervent Radiol ; 36(4): 1161-4, 2013 Aug.
Article in English | MEDLINE | ID: mdl-22996588

ABSTRACT

A case of surgically created splenorenal shunt complicated with shunt myelopathy was successfully managed by placement of a stent graft within the splenic vein to close the portosystemic shunt and alleviate myelopathy. To our knowledge, this is the first report of a case of shunt myelopathy in a patient with noncirrhotic portal fibrosis without cirrhosis treated by a novel technique wherein a transjugular intrahepatic route was adopted to deploy the stent graft.


Subject(s)
Hypertension, Portal/surgery , Portasystemic Shunt, Transjugular Intrahepatic/adverse effects , Spinal Cord Diseases/etiology , Spinal Cord Diseases/therapy , Stents , Adult , Endovascular Procedures/methods , Follow-Up Studies , Humans , Hypertension, Portal/pathology , Male , Portasystemic Shunt, Transjugular Intrahepatic/methods , Rare Diseases , Risk Assessment , Spinal Cord Diseases/pathology , Tomography, X-Ray Computed/methods , Treatment Outcome , Ultrasonography, Doppler, Pulsed
SELECTION OF CITATIONS
SEARCH DETAIL